Showing results (131-140 of 208) with videos related to

Sort By:
Pageof 21
Nature Communications|May 31, 2022
Multicenter phase II trial of Camrelizumab combined with Apatinib and Eribulin in heavily pretreated patients with advanced triple-negative breast cancerJieqiong Liu, Ying Wang, Zhenluan Tian, et al.
Nature Communications|November 3, 2020
LncRNA DILA1 inhibits Cyclin D1 degradation and contributes to tamoxifen resistance in breast cancerQianfeng Shi, Yudong Li, Shunying Li, et al.
Cell Reports|March 31, 2015
The Rab2A GTPase promotes breast cancer stem cells and tumorigenesis via Erk signaling activationMan-Li Luo, Chang Gong, Chun-Hau Chen, et al.
Translational Breast Cancer Research : a Journal Focusing on Translational Research in Breast Cancer|May 16, 2024
Chinese Society of Clinical Oncology (CSCO) Breast Cancer Guidelines 2022Zefei Jiang, Jianbin Li, Jiayi Chen, et al.
Plant Physiology|January 11, 2024
A Streptomyces species from the ginseng rhizosphere exhibits biocontrol potentialJiaquan Huang, Xiaojie Li, Xuanlin Zhan, et al.
Translational Breast Cancer Research : a Journal Focusing on Translational Research in Breast Cancer|February 12, 2026
Chinese expert consensus on endocrine therapy for breast cancer (2026 edition)Yang Yuan, Yongmei Yin, Shu Wang, et al.
Acta Pharmaceutica Sinica. B|July 19, 2024
LncRNA ZFPM2-AS1 promotes phyllodes tumor progression by binding to CDC42 and inhibiting STAT1 activationShishi He, Guowei Huang, Rong Lei, et al.
Oncogene|November 4, 2022
The lncRNA THOR interacts with and stabilizes hnRNPD to promote cell proliferation and metastasis in breast cancerHongtao Hu, Hanqiu Zhang, Yue Xing, et al.
BMJ (Clinical Research Ed.)|September 11, 2025
Effect of methylcobalamin on capecitabine induced hand-foot syndrome in patients with HER2 negative early breast cancer: multicentre, double blind, randomised, placebo controlled, phase 3 trialYuan Xia, Yingying Zhu, Li Ling, et al.
Translational Breast Cancer Research : a Journal Focusing on Translational Research in Breast Cancer|August 4, 2025
Chinese expert consensus on clinical diagnosis and treatment of breast cancer targeting HER2Jianbin Li, Yueping Liu, Shu Wang, et al.
Pageof 21